• No results found

HMG CO A reductase

INHIBITION OF 3 HYDROXY 3 METHYLGLUTARYL COENZYME A (HMG Co A) REDUCTASE IN LIVER MICROSOMES BY MORINGA OLEIFERA L  POLYPHENOLS

INHIBITION OF 3 HYDROXY 3 METHYLGLUTARYL COENZYME A (HMG Co A) REDUCTASE IN LIVER MICROSOMES BY MORINGA OLEIFERA L POLYPHENOLS

... CoA) reductase, which is the enzyme responsible for conversion of HMG CoA to mevalonate and a rate limiting step in cholesterol biosynthesis, can achieve relatively large reductions in plasma cholesterol ...

7

INCREASE OF SERUM BCL-2 CONCENTRATION IN SEVERE HEAD INJURY: The Role of ACTH4-10Pro8Gly9Pro10 and HMG Co-A Reductase Inhibitor

INCREASE OF SERUM BCL-2 CONCENTRATION IN SEVERE HEAD INJURY: The Role of ACTH4-10Pro8Gly9Pro10 and HMG Co-A Reductase Inhibitor

... CoA) reductase inhibitors (statins) are the most commonly prescribed drugs used to combat ...synthesis, HMG-CoA ...the HMG-CoA reductase family of drugs and has recently been described as ...

6

Insilico predictions of inhibitors of novel statin structural analogues with HMG CoA reductase

Insilico predictions of inhibitors of novel statin structural analogues with HMG CoA reductase

... of HMG-Co A reductase with known crystal structure of four chains has been identified and down loaded from the National Centre for Biotechnology and the detail pertaining to the molecular properties ...

9

3-HMG-CoA Reductase Inhibitors and Inflammation: Underlying Mechanisms and Role in Atherosclerosis
 

3-HMG-CoA Reductase Inhibitors and Inflammation: Underlying Mechanisms and Role in Atherosclerosis  

... An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in ...

7

Exploration of natural product ingredients as inhibitors of human HMG-CoA reductase through structure-based virtual screening

Exploration of natural product ingredients as inhibitors of human HMG-CoA reductase through structure-based virtual screening

... atherosclerosis. HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase is the key enzyme in the cholesterol biosynthesis pathway, and the statin-like drugs are inhibitors of human HMG-CoA ...

12

Aplexone targets the HMG CoA reductase pathway and differentially regulates arteriovenous angiogenesis

Aplexone targets the HMG CoA reductase pathway and differentially regulates arteriovenous angiogenesis

... Arterial and venous endothelial cells exhibit distinct molecular characteristics at early developmental stages. These lineage- specific molecular programs are instructive to the development of distinct vascular ...

9

Role of HMG-CoA reductase inhibitors with curative radiotherapy in men with prostate cancer

Role of HMG-CoA reductase inhibitors with curative radiotherapy in men with prostate cancer

... Abstract: Brachytherapy and external beam radiotherapy are effective and commonly used treatment modalities in men with localized prostate cancer. In this review, we explore the role of radiation therapy in the curative ...

10

The effect of aerobic training and consumption of L-carnitine supplements on Gen expression of HMG-CoA reductase and LDL receptor in the liver of male Wistar rats Injected by Boldenone

The effect of aerobic training and consumption of L-carnitine supplements on Gen expression of HMG-CoA reductase and LDL receptor in the liver of male Wistar rats Injected by Boldenone

... cholesterol reductase synthesis regulating enzyme namely HMG-COA ...of HMG- COA reductase ...reduced, HMG-COA reductase is positively ...of HMG-COA reductase ...

12

56. Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (ex vivo) by medicinal plants from western ghats

56. Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (ex vivo) by medicinal plants from western ghats

... For the assay of 3-hydroxy-3-methylglutaryl CoA reductase, the incubation mixtures contain 0.5-1.0 mg of microsomal protein, 150 nmoles of HMG- CoA, and 2ìmoles of NADPH. These components are added to 0.8 ...

6

Original Article Malignant fibrous histiocytoma of visceral organs: clinicopathologic features and diagnostic value of ezrin and HMG-CoA reductase

Original Article Malignant fibrous histiocytoma of visceral organs: clinicopathologic features and diagnostic value of ezrin and HMG-CoA reductase

... of HMG-CoA reductase, have been proved as chemopreventive drugs for variable ...of HMG-CoA reductase in most of the breast cancer cases, which was associated with an improved prog- nosis ...

12

An improved industrial process for synthesis of HMG-CoA reductase inhibitor Pitavastatin

An improved industrial process for synthesis of HMG-CoA reductase inhibitor Pitavastatin

... way. HMG-CoA reductase inhibitors are better antagonists for blocking the biosynthesis pathway of ...(or HMG-CoA reductase inhibitors) form a class of hypolipidemic agents, used as ...

6

Towards Application of Bioactive Natural Products Containing Isoprenoids for the Regulation of HMG CoA Reductase—A Review

Towards Application of Bioactive Natural Products Containing Isoprenoids for the Regulation of HMG CoA Reductase—A Review

... isoprenoids. HMG-CoA reduc- tase is a rate-determining enzyme in mevalonate pathway, producing intermediates such as farnesyl and geranylgeranyl pyrophosphates, which lead to by-products such as ...of ...

11

Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo

Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo

... Background: HMG-CoA reductase inhibitors (statins) are commonly used in medicine to control blood lipid ...of HMG-CoA reductase inhibitors has been reported to have immunosuppressive ...

5

HMG-CoA reductase inhibitor lovastatin upregulates plasminogen activator production through RhoA-signaling in peritoneal cell line Met5A

HMG-CoA reductase inhibitor lovastatin upregulates plasminogen activator production through RhoA-signaling in peritoneal cell line Met5A

... (HMG-CoA) reductase inhibitor statin, known to protect postoperative adhesion in animal model, affect the expressing tissue-type plasminogen activator (tPA) in peritoneal cells in ...of HMG-CoA ...

5

Pleiotropic effects of the HMG-CoA reductase inhibitors

Pleiotropic effects of the HMG-CoA reductase inhibitors

... Abstract: The HMG-CoA reductase inhibitors (statins) are used extensively in the treatment of hyperlipidemia. They have also demonstrated a benefit in a variety of other disease processes. These secondary ...

11

CHRONOPHARMACOTHERAPEUTIC RELEASE OF HMG   COA REDUCTASE INHIBITOR: USING NOVEL COATING TECHNIQUE

CHRONOPHARMACOTHERAPEUTIC RELEASE OF HMG COA REDUCTASE INHIBITOR: USING NOVEL COATING TECHNIQUE

... words, it is required that the drug should not be released at all during the initial phase of dosage form administration. Such a release pattern is known as pulsatile release. [2] There are many conditions that demand ...

14

7 Dehydrocholesterol–dependent proteolysis of HMG CoA reductase suppresses sterol biosynthesis in a mouse model of Smith Lemli Opitz/RSH syndrome

7 Dehydrocholesterol–dependent proteolysis of HMG CoA reductase suppresses sterol biosynthesis in a mouse model of Smith Lemli Opitz/RSH syndrome

... of HMG-CoA reductase enzyme catabolism. Stability of HMG-CoA reductase was stud- ied in an in vitro system developed by Simoni and col- leagues, which employs a fusion gene (HMGal) consist- ...

12

Synthesis of HMG-CoA Reductase Inhibitor Lanost-8-en-3β-ol-7, 11-dione through Oxidation of 3β-acetoxylanost-8-en-7, 11-dione with Pyridinium Chlorochromate

Synthesis of HMG-CoA Reductase Inhibitor Lanost-8-en-3β-ol-7, 11-dione through Oxidation of 3β-acetoxylanost-8-en-7, 11-dione with Pyridinium Chlorochromate

... Allylic oxidation of 3B-acetoxylanost-8-ene was accomplished with pyridinium chlorochromate (PCC) and chromium trioxide/ acetic acid to form 3B- acetoxylanost-8-en-7,11-dione, which was later reduced to ...

8

The clinical significance of statins-macrolides interaction: comprehensive review of in vivo studies, case reports, and population studies

<p>The clinical significance of statins-macrolides interaction: comprehensive review of in vivo studies, case reports, and population studies</p>

... Abstract: The objectives of this article were to review the mechanism and clinical sig- ni fi cance of statins-macrolides interaction, determine which combination has the highest risk for the interaction, and identify key ...

16

Statins in Candidemia: clinical outcomes from a matched cohort study

Statins in Candidemia: clinical outcomes from a matched cohort study

... CoA) reductase inhibitors (statins) in improving outcomes bac- teremic sepsis is currently being debated with recent papers showing significantly improved survival in patients with systemic inflammatory response ...

8

Show all 10000 documents...

Related subjects